Altor Bioscience is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Altor Bioscience is developing and marketing.
Altor Bioscience doesn't have any recent trademark applications, indicating Altor Bioscience is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IMMUNOCONDIMENT Pharmaceuticals, namely, therapeutic agents for the treatment of a variety of diseases and disorders, namely, neoplasia, infectious diseases and immune-related diseases and disorders
09/16/2016
STAR Diagnostic preparations and therapeutic preparations in the nature of reagents, polypeptides, recombinant proteins for clinical or medical laboratory use and for use in the treatment of cancer, viral infections, and autoimmune diseases
07/25/2003
See all trademarks and details in the Full Report.
Market Share of Altor Bioscience's Largest Competitors
A competitive analysis shows these companies are in the same general field as Altor Bioscience, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Altor Bioscience.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Altor Bioscience's Fastest Growing Competitors
These companies are in the same general field as Altor Bioscience and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.